iBio (IBIO) Other Accumulated Expenses (2011 - 2024)

iBio (IBIO) has reported Other Accumulated Expenses for 7 consecutive years, with $460000.0 the latest figure, recorded in Q2 2024.

• In Q2 2024, Other Accumulated Expenses rose 130.0% year-over-year to $460000.0; the TTM figure through Jun 2024 stood at $460000.0 (up 130.0% YoY), while the FY2024 annual figure was $460000.0, up 130.0% from the prior year.
• Other Accumulated Expenses rose to $460000.0 in Q2 2024 per IBIO's latest filing, from $200000.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $460000.0 in Q2 2024 and bottomed at $136000.0 in Q2 2021.
• Historically, Other Accumulated Expenses has averaged $238400.0 across 5 years, with a median of $200000.0 in 2023.
• Annual changes were most pronounced in 2021 — Other Accumulated Expenses declined 18.56% — and 2024, when it soared 130.0%.
• iBio's Other Accumulated Expenses stood at $167000.0 in 2020, then decreased by 18.56% to $136000.0 in 2021, then jumped by 68.38% to $229000.0 in 2022, then retreated by 12.66% to $200000.0 in 2023, then jumped by 130.0% to $460000.0 in 2024.
• Business Quant data shows IBIO's Other Accumulated Expenses at $460000.0 in Q2 2024, $200000.0 in Q2 2023, and $229000.0 in Q2 2022.